At GoodRx, Douglas Hirsch has seen notable changes in his stock holdings. In 2021, he had vested stock units worth over $92 million due to prior IPO grants, which showcased the peak of his wealth connected to the company's success....

At GoodRx, Douglas Hirsch has seen notable changes in his stock holdings. In 2021, he had vested stock units worth over $92 million due to prior IPO grants, which showcased the peak of his wealth connected to the company's success. However, no stock awards were made in 2022 or 2023, as he had already received substantial compensation. His focus has now shifted towards guiding the company's mission, rather than day-to-day stock performance. As GoodRx transforms under new leadership, Hirsch's previous stakes underline the financial trust in the company he helped build. While he still maintains a presence in GoodRx, the fluctuations in his holdings reflect both his investment and commitment to the company's future.